Craig Blanchette

Craig is an experienced scientist and leader in the field of drug discovery, with expertise across multiple drug modalities including RNA and protein therapies. Craig led a drug discovery department at Genentech and played a leading role developing the RNA

therapeutic and delivery strategy. In addition to his experience in onboarding new modalities, he also has expertise in drug development of protein-based therapeutics across a broad range of therapeutic areas. Prior to joining Genentech, Craig was a staff

scientist in the Biological Sciences Department at Lawrence Livermore National Laboratories and led a team to build multiple vaccine programs using novel nanoparticle technology. He holds a Ph.D. in Biophysics from the University of California, Davis and a B.S. in Biology and Physics from Vassar College.